SEC Form 4 · accession 0001209191-19-003027
Ampio Pharmaceuticals, Inc. · AMPE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Philip H Coelho
Director
Period of report
Dec 15, 2018
Accepted (ET)
Jan 9, 2019 · 4:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411906
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.40 | Dec 15, 2018 | A | 30,000 | A | — | Dec 15, 2028 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1The stock option vests and becomes exercisable in 12 equal monthly installments from the date of grant.